09/07/2017
Please Read Once, it will help you definitely.
The Prohibited List is a cornerstone of the World Anti-Doping Code and a key component of harmonization. The List is updated annually following an extensive consultation process facilitated by WADA.
The 2017 List is valid from January 1 to December 31, 2017.
PROHIBITED AT ALL TIMES(IN- AND OUT-OF-COMPETITION)
Non-approved substances
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
1. Any pharmacological substance which is not addressed by any of the subsequent sections of the List and with no current approval by any governmental regulatory health authority for human therapeutic use (e.g. drugs under pre-clinical or clinical development or discontinued, designer drugs, substances approved only for veterinary use) is prohibited at all times.
Anabolic agents
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
Anabolic agents are prohibited.
1. ANABOLIC ANDROGENIC STEROIDS (AAS)
A. EXOGENOUS * AAS, INCLUDING:
1-androstenediol (5α-androst-1-ene-3β,17β-diol)
1-androstenedione (5α-androst-1-ene-3,17-dione)
1-testosterone (17β-hydroxy-5α-androst-1-en-3-one)
4-hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3-one)
Bolandiol (estr-4-ene-3β,17β-diol)
Bolasterone
Calusterone
Clostebol
Danazol ([1,2]oxazolo[4',5':2,3]pregna-4-en-20-yn-17α-ol)
Dehydrochlormethyltestosterone (4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Desoxymethyltestosterone (17α-methyl-5α-androst-2-en-17β-ol)
Drostanolone
Ethylestrenol (19-norpregna-4-en-17α-ol)
Fluoxymesterone
Formebolone
Furazabol (17α-methyl [1,2,5]oxadiazolo[3',4':2,3]-5α-androstan-17β-ol)
Gestrinone
Mestanolone
Mesterolone
Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Metenolone
Methandriol
Methasterone (17β-hydroxy-2α,17α-dimethyl-5α-androstan-3-one)
Methyldienolone (17β-hydroxy-17α-methylestra-4,9-dien-3-one)
Methyl-1-testosterone (17β-hydroxy-17α-methyl-5α-androst-1-en-3-one)
Methylnortestosterone (17β-hydroxy-17α-methylestr-4-en-3-one)
Methyltestosterone
Metribolone (methyltrienolone, 17β-hydroxy-17α-methylestra-4,9,11-trien-3-one)
Mibolerone
Norboletone
Norclostebol
Norethandrolone
Oxabolone
Oxandrolone
Oxymesterone
Oxymetholone
Prostanozol (17β-[(tetrahydropyran-2-yl)oxy]-1'H-pyrazolo[3,4:2,3]-5α-androstane)
Quinbolone
Stanozolol
Stanozolol
Stenbolone
Stenbolone
Tetrahydrogestrinone (17-hydroxy-18a-homo-19-nor-17α-pregna-4,9,11-trien-3-one)
Trenbolone (17β-hydroxyestr-4,9,11-trien-3-one)
and other substances with a similar chemical structure or similar biological effect(s).
B. ENDOGENOUS** AAS WHEN ADMINISTERED EXOGENOUSLY:
19-norandrostenediol (estr-4-ene-3,17-diol)
19-norandrostenedione (estr-4-ene-3,17-dione)
Androstenediol (androst-5-ene-3β,17β-diol)
Androstenedione (androst-4-ene-3,17-dione)
Boldenone
Boldione (androsta-1,4-diene-3,17-dione)
Dihydrotestosterone (17β-hydroxy-5α-androstan-3-one)
Nandrolone (19-nortestosterone)
Prasterone (dehydroepiandrosterone, DHEA, 3β-hydroxyandrost-5-en-17-one)
Testosterone
and their metabolites and isomers, including but not limited to:
3β-hydroxy-5α-androstan-17-one
5α-androst-2-ene-17-one
5α-androstane-3α,17α-diol
5α-androstane-3α,17β-diol
5α-androstane-3β,17α-diol
5α-androstane-3β,17β-diol
5β-androstane-3α,17β-diol
7α-hydroxy-DHEA
7β-hydroxy-DHEA
4-androstenediol (androst-4-ene-3β,17β-diol)
5-androstenedione (androst-5-ene-3,17-dione)
7-keto-DHEA
19-norandrosterone
19-noretiocholanolone
Androst-4-ene-3α,17α-diol
Androst-4-ene-3α,17β-diol
Androst-4-ene-3β,17α-diol
Androst-5-ene-3α,17α-diol
Androst-5-ene-3α,17β-diol
Androst-5-ene-3β,17α-diol
Androsterone
Epi-dihydrotestosterone
Epitestosterone
Etiocholanolone
2. OTHER ANABOLIC AGENTS
Including, but not limited to:
Clenbuterol
Selective androgen receptor modulators (SARMs), e.g. andarine and ostarine;
Tibolone
Zeranol
Zilpaterol
For purposes of this section:
* “ exogenous” refers to a substance which is not ordinarily produced by the body naturally.
** “ endogenous” refers to a substance which is ordinarily produced by the body naturally.
Peptide hormones, growth factors, related substances and mimetics
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
The following substances, and other substances with similar chemical structure or similar biological effect(s), are prohibited:
1. ERYTHROPOIETIN-RECEPTOR AGONISTS:
1.1 ERYTHROPOIESIS-STIMULATING AGENTS (ESAS) INCLUDING E.G.
Darbepoietin (dEPO)
Erythropoietins (EPO)
EPO-Fc
EPO-mimetic peptides (EMP), e.g. CNTO 530 and peginesatide;
GATA inhibitors , e.g. K-11706;
Methoxy polyethylene glycol-epoetin beta (CERA)
Transforming Growth Factor-β (TGF-β) inhibitors , e.g. sotatercept, luspatercept;
1.2 NON-ERYTHROPOIETIC EPO-RECEPTOR AGONISTS, E.G
ARA-290
Asialo EPO
Carbamylated EPO
2. HYPOXIA-INDUCIBLE FACTOR (HIF) STABILIZERS, E.G.
Cobalt
Molidustat
Roxadustat
and HIF activators, e.g.
Argon
Xenon
4 3. CHORIONIC GONADOTROPHIN (CG) AND LUTEINIZING HORMONE (LH) AND THEIR RELEASING FACTORS, E.G.
Buserelin
Gonadorelin
Leuprorelin , in males;
4. CORTICOTROPHINS AND THEIR RELEASING FACTORS, E.G.
Corticorelin
GROWTH HORMONE (GH) AND ITS RELEASING FACTORS INCLUDING:
Growth Hormone Releasing Hormone (GHRH), and its analogues, e.g. CJC-1295, sermorelin and tesamorelin;
Growth Hormone Secretagogues (GHS), e.g. ghrelin and ghrelin mimetics, e.g. anamorelin and ipamorelin;
GH-Releasing Peptides (GHRPs), e.g. alexamorelin, GHRP-6, hexarelin, and pralmorelin (GHRP-2);
Additional prohibited growth factors:
Fibroblast Growth Factors (FGFs)
Hepatocyte Growth Factor (HGF)
Insulin-like Growth Factor-1 (IGF-1), and its analogues;
Mechano Growth Factors (MGFs)
Platelet-Derived Growth Factor (PDGF)
Vascular-Endothelial Growth Factor (VEGF)
and any other growth factor affecting muscle, tendon or ligament protein synthesis/degradation, vascularisation, energy utilization, regenerative capacity, or fibre type switching.
Beta-2 agonists
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
All selective and non-selective beta-2 agonists, including all optical isomers, are prohibited;
Including, but not limited to:
Fenoterol
Formoterol
Higenamine
Indacaterol
Olodaterol
Procaterol
Reproterol
Salbutamol
Salmeterol
Terbutaline
Vilanterol
Except:
Inhaled salbutamol: maximum 1600 micrograms over 24 hours, not to exceed 800 micrograms every 12 hours;Inhaled formoterol: maximum delivered dose of 54 micrograms over 24 hours;Inhaled salmeterol: maximum 200 micrograms over 24 hours.
The presence in urine of salbutamol in excess of 1000 ng/mL or formoterol in excess of 40 ng/mL is presumed not to be an intended therapeutic use of the substance and will be considered as an Adverse Analytical Finding (AAF) unless the Athlete proves, through a controlled pharmacokinetic study, that the abnormal result was the consequence of the use of the therapeutic dose (by inhalation) up to the maximum dose indicated above.
Hormone and metabolic modulators
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
The following hormone and metabolic modulators are prohibited:
1. Aromatase inhibitors including, but not limited to:
4-androstene-3,6,17 trione (6-oxo)
Aminoglutethimide
Anastrozole
Androsta-1,4,6-triene-3,17-dione (androstatrienedione)
Androsta-3,5-diene-7,17-dione (arimistane)
Exemestane
Formestane
Letrozole
Testolactone
2. Selective estrogen receptor modulators (SERMs) including, but not limited to:
Raloxifene
Tamoxifen
Toremifene
3. Other anti-estrogenic substances including, but not limited to:
Clomiphene
Cyclofenil
Fulvestrant
4. Agents modifying myostatin function(s) including, but not limited, to:
Myostatin inhibitors
5. Metabolic modulators:
Activators of the AMP-activated protein kinase (AMPK), eg. AICAR;
Peroxisome Proliferator Activated Receptor δ (PPARδ) agonists , e.g. GW 1516;
Insulins , and insulin-mimetics;
Meldonium
Trimetazidine
S5
Diuretics and masking agents
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
The following diuretics and masking agents are prohibited, as are other substances with a similar chemical structure or similar biological effect(s).
Including, but not limited to:
Desmopressin; probenecid; plasma expanders, e.g. glycerol and intravenous administration of albumin, dextran, hydroxyethyl starch and mannitol.Acetazolamide; amiloride; bumetanide; canrenone; chlortalidone; etacrynic acid; furosemide; indapamide; metolazone; spironolactone; thiazides, e.g. bendroflumethiazide, chlorothiazide and hydrochlorothiazide; triamterene and vaptans, e.g. tolvaptan.
Except:
Drospirenone; pamabrom; and ophthalmic use of carbonic anhydrase inhibitors (e.g. dorzolamide, brinzolamide).Local administration of felypressin in dental anaesthesia.
The detection in an Athlete’s Sample at all times or In-Competition, as applicable, of any quantity of the following substances subject to threshold limits: formoterol, salbutamol, cathine, ephedrine, methylephedrine and pseudoephedrine, in conjunction with a diuretic or masking agent, will be considered as an Adverse Analytical Finding (AAF) unless the Athlete has an approved Therapeutic Use Exemption (TUE) for that substance in addition to the one granted for the diuretic or masking agent
M1
Manipulation of blood and blood components
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
The following are prohibited:
1. The Administration or reintroduction of any quantity of autologous, allogenic (homologous) or heterologous blood, or red blood cell products of any origin into the circulatory system.
2. Artificially enhancing the uptake, transport or delivery of oxygen.
Including, but not limited to:
Perfluorochemicals; efaproxiral (RSR13) and modified haemoglobin products, e.g. haemoglobin-based blood substitutes and microencapsulated haemoglobin products, excluding supplemental oxygen by inhalation.
3. Any form of intravascular manipulation of the blood or blood components by physical or chemical means.
M1
Manipulation of blood and blood components
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
The following are prohibited:
1. The Administration or reintroduction of any quantity of autologous, allogenic (homologous) or heterologous blood, or red blood cell products of any origin into the circulatory system.
2. Artificially enhancing the uptake, transport or delivery of oxygen.
Including, but not limited to:
Perfluorochemicals; efaproxiral (RSR13) and modified haemoglobin products, e.g. haemoglobin-based blood substitutes and microencapsulated haemoglobin products, excluding supplemental oxygen by inhalation.
3. Any form of intravascular manipulation of the blood or blood components by physical or chemical means.
M2
Chemical and physical manipulation
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
The following are prohibited:
1. Tampering, or Attempting to Tamper, to alter the integrity and validity of Samples collected during Doping Control.
Including, but not limited to:
Urine substitution and/or adulteration, e.g. proteases.
2. Intravenous infusions and/or injections of more than 50 mL per 6 hour period except for those legitimately received in the course of hospital admissions, surgical procedures or clinical investigations.
M3
Gene doping
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
The following, with the potential to enhance sport performance, are prohibited:
1. The transfer of polymers of nucleic acids or nucleic acid analogues;
2. The use of normal or genetically modified cells.
PROHIBITED IN-COMPETITION
S6
Stimulants
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
All stimulants, including all optical isomers, e.g. d- and l- where relevant, are prohibited.
Stimulants include:
NON-SPECIFIED STIMULANTS:
Adrafinil
Amfepramone
Amfetamine
Amfetaminil
Amiphenazole
Benfluorex
Benzylpiperazine
Bromantan
Clobenzorex
Co***ne
Cropropamide
Crotetamide
Fencamine
Fenetylline
Fenfluramine
Fenproporex
Fonturacetam , [4-phenylpiracetam (carphedon)];
Furfenorex
Lisdexamfetamine
Mefenorex
Mephentermine
Mesocarb
Metamfetamine(d-)
P-methylamphetamine
Modafinil
Norfenfluramine
Phendimetrazine
Phentermine
Prenylamine
Prolintane
A stimulant not expressly listed in this section is a Specified Substance.
SPECIFIED STIMULANTS.
Including, but not limited to:
4-methylhexan-2-amine (methylhexaneamine)
Benzfetamine
Cathine**
Cathinone , and its analogues, e.g. mephedrone, methedrone, and α-pyrrolidinovalerophenone;
Dimethylamphetamine
Ephedrine***
Epinephrine**** (adrenaline)
Etamivan
Etilamfetamine
Etilefrine
Famprofazone
Fenbutrazate
Fencamfamin
Heptaminol
Hydroxyamfetamine (parahydroxyamphetamine)
Isometheptene
Levmetamfetamine
Meclofenoxate
Methylenedioxymethamphetamine
Methylephedrine***
Methylphenidate
Nikethamide
Norfenefrine
Octopamine
Oxilofrine (methylsynephrine)
Pemoline
Pentetrazol
Phenethylamine , and its derivatives;
Phenmetrazine
Phenpromethamine
Propylhexedrine
Pseudoephedrine*****
Selegiline
Sibutramine
Strychnine
Tenamfetamine (methylenedioxyamphetamine)
Tuaminoheptane
and other substances with a similar chemical structure or similar biological effect(s).
Except:
ClonidineImidazole derivatives for topical/ophthalmic use and those stimulants included in the 2017 Monitoring Program*.
* Bupropion, caffeine, ni****ne, phenylephrine, phenylpropanolamine, pipradrol, and synephrine: These substances are included in the 2017 Monitoring Program, and are not considered Prohibited Substances.
** Cathine: Prohibited when its concentration in urine is greater than 5 micrograms per milliliter.
*** Ephedrine and methylephedrine: Prohibited when the concentration of either in urine is greater than 10 micrograms per milliliter.
**** Epinephrine (adrenaline): Not prohibited in local administration, e.g. nasal, ophthalmologic, or co-administration with local anaesthetic agents.
***** Pseudoephedrine: Prohibited when its concentration in urine is greater than 150 micrograms per milliliter.
S7
Narcotics
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
Prohibited:
Buprenorphine
Dextromoramide
Diamorphine (he**in)
Fentanyl , and its derivatives;
Hydromorphone
Methadone
Morphine
Nicomorphine
Oxycodone
Oxymorphone
Pentazocine
Pethidine
S8
Cannabinoids
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
Prohibited:
Natural, e.g. cannabis, hashish and ma*****na, or synthetic Δ9-tetrahydrocannabinol (THC).Cannabimimetics, e.g. “Spice”, JWH-018, JWH-073, HU-210.
S9
Glucocorticoids
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
All glucocorticoids are prohibited when administered by oral, intravenous, intramuscular or re**al routes.
PROHIBITED IN ,PARTICULAR SPORTS
Alcohol
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
Alcohol (ethanol) is prohibited In-Competition only, in the following sports. Detection will be conducted by analysis of breath and/or blood. The doping violation threshold is equivalent to a blood alcohol concentration of 0.10 g/L.
Air Sports (FAI)Archery (WA)Automobile (FIA)Powerboating (UIM)
P2
Beta-blockers
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
Beta-blockers are prohibited In-Competition only, in the following sports, and also prohibited Out-of-Competition where indicated.
Archery (WA)*Automobile (FIA)Billiards (all disciplines) (WCBS)Darts (WDF)Golf (IGF)Shooting (ISSF, IPC)*Skiing/Snowboarding (FIS) in ski jumping, freestyle aerials/halfpipe and snowboard halfpipe/big airUnderwater sports (CMAS) in constant-weight apnoea with or without fins, dynamic apnoea with and without fins, free immersion apnoea, Jump Blue apnoea, spearfishing, static apnoea, target shooting and variable weight apnoea.
*Also prohibited Out-of-Competition
Including, but not limited to:
Acebutolol
Alprenolol
Atenolol
Betaxolol
Bisoprolol
Bunolol
Carteolol
Carvedilol
Celiprolol
Esmolol
Labetalol
Levobunolol
Metipranolol
Metoprolol
Nadolol
Oxprenolol
Pindolol
Propranolol
Sotalol
Timolol